What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His scientific interests lie mostly in Immunology, Pathology, Internal medicine, Langerhans cell histiocytosis and Histiocytosis.
His work deals with themes such as Mycobacterium bovis and Tuberculosis, which intersect with Immunology.
His research in Pathology intersects with topics in Mutation, Hematology and Immunophenotyping.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Surgery and Oncology.
His biological study spans a wide range of topics, including Targeted therapy, Colorectal cancer, KRAS and Hazard ratio.
The Histiocytosis study combines topics in areas such as Malignant histiocytosis, Biopsy and Nose.
His most cited work include:
- KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer (1905 citations)
- KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab (1279 citations)
- INTERFERON-GAMMA-RECEPTOR DEFICIENCY IN AN INFANT WITH FATAL BACILLE CALMETTE-GUERIN INFECTION (767 citations)
What are the main themes of his work throughout his whole career to date?
Jean-François Emile spends much of his time researching Internal medicine, Pathology, Oncology, Cancer research and Histiocytosis.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Surgery.
In most of his Pathology studies, his work intersects topics such as Langerhans cell.
The study incorporates disciplines such as KRAS, Cetuximab, FOLFOX and Prospective cohort study in addition to Oncology.
His Cancer research study integrates concerns from other disciplines, such as Mutation and Immunology.
His Histiocytosis research integrates issues from Histiocyte, Dermatology and Biopsy.
He most often published in these fields:
- Internal medicine (36.04%)
- Pathology (29.54%)
- Oncology (22.22%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (36.04%)
- Histiocytosis (15.18%)
- Oncology (22.22%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Histiocytosis, Oncology, Erdheim–Chester disease and Cancer research.
Internal medicine is often connected to Gastroenterology in his work.
Histiocytosis is the subject of his research, which falls under Pathology.
In his study, Rare disease is inextricably linked to Langerhans cell, which falls within the broad field of Pathology.
His Oncology study combines topics in areas such as Pembrolizumab, Stage III Colon Cancer, Chemotherapy, Adverse effect and Adenocarcinoma.
His work in Colorectal cancer covers topics such as Immune system which are related to areas like Cytokine.
Between 2018 and 2021, his most popular works were:
- Pangenomic Classification of Pituitary Neuroendocrine Tumors. (48 citations)
- Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study. (40 citations)
- Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study (31 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Jean-François Emile mainly focuses on Cancer research, Internal medicine, Colorectal cancer, Histiocytosis and Gastroenterology.
His Internal medicine research is multidisciplinary, incorporating perspectives in Microbiome and Oncology.
As a part of the same scientific study, Jean-François Emile usually deals with the Colorectal cancer, concentrating on Immune system and frequently concerns with Stromal cell, Stroma, Fibrosis and Inflammation.
His Histiocytosis study is concerned with Pathology in general.
His Pathology research is multidisciplinary, incorporating elements of Langerhans cell and Concomitant.
He has included themes like KRAS and Pathological in his Gastroenterology study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
